EP63 FIRST IN HUMAN TRIAL OF IMU-856, AN ORALLY AVAILABLE REGULATOR OF BARRIER FUNCTION FOR THE TREATMENT OF CELIAC DISEASE

Authors:
  • FBFranziska Buriánek
    Franziska Buriánek
  • TPThomas Polasek
    Thomas Polasek
  • JMJelena Mihajlovic
    Jelena Mihajlovic
  • EPEvelyn Peelen
    Evelyn Peelen
  • JFJuliano Fonseca
    Juliano Fonseca
  • MWMartina Wirth
    Martina Wirth
  • IKInge Kehler
    Inge Kehler
  • DVDaniel Vitt
    Daniel Vitt
  • HKHella Kohlhof
    Hella Kohlhof
  • AMAndreas Muehler
    Andreas Muehler

Abstract
No abstract available